{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":8,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":8,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"60af21122bd7","filters":{"venue":"Journal of Bioequivalence & Bioavailability"}},"results":[{"id":"W4235998499","doi":"10.4172/jbb","title":"Journal of Bioequivalence & Bioavailability","year":2018,"lang":"fr","type":"paratext","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada","keywords":"Bioequivalence; Bioavailability; Pharmacology; Computational biology; Medicine; Computer science; Biology","authors":[{"name":"Cassandre Legault","is_ca":true},{"name":"Jun Li","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03540523483618972,"gpt":0.3246727591486874,"spread":0.2892675243124976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004523464,0.0006185138,0.0008603885,0.002637021,0.0005903718,0.00319651,0.0005777073,0.001531742,0.03901254],"category_scores_gemma":[0.01059125,0.0002031525,0.0003831814,0.002416395,0.001325721,0.001495776,0.0009502147,0.001463574,0.01332415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001288071,"about_ca_system_score_gemma":0.00205554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00108835,"about_ca_topic_score_gemma":0.0008649905,"domain_scores_codex":[0.9965042,0.0009570896,0.0003300338,0.0002378328,0.00188369,0.00008720082],"domain_scores_gemma":[0.9958773,0.001757434,0.0005829247,0.0003776615,0.001265075,0.0001396867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006059216,0.0005100629,0.001923957,0.002064772,0.0001045242,0.0002260823,0.000202441,0.002168583,0.01571519,0.08079276,0.084803,0.8108827],"study_design_scores_gemma":[0.0001216578,0.001104969,0.01170019,0.0008246097,0.0001177286,0.001190082,0.0001340771,0.007146005,0.01856039,0.05017304,0.9088655,0.00006189588],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.03302616,0.1611778,0.108363,0.02029227,0.007147899,0.001606992,0.00519779,0.0008665785,0.6623216],"genre_scores_gemma":[0.4595816,0.1244663,0.0811077,0.002645124,0.007709602,0.001634192,0.004375573,0.0006560466,0.3178239],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9609874,"threshold_uncertainty_score":0.13051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2537045987","doi":"10.4172/jbb.1000250","title":"Designing, Development and Formulation of Mouth Disintegrating Telmisartan Tablet with Extended Release Profile Using Response Surface Methodology","year":2015,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Telmisartan; Pharmacology; Response surface methodology; Computer science; Biochemical engineering; Medicine; Biomedical engineering; Engineering; Machine learning; Internal medicine","authors":[{"name":"Muhammad Akram","is_ca":false},{"name":"Taha Nazir","is_ca":true},{"name":"Nida Taha","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3508444658438323,"gpt":0.4503953101799497,"spread":0.09955084433611738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003750389,0.0002870782,0.0003692097,0.000277142,0.0001058423,0.0003718059,0.0002588271,0.0003965952,0.000857736],"category_scores_gemma":[0.0002756794,0.0001668396,0.0004889649,0.000225643,0.0001260341,0.0003378905,0.0001412115,0.0004702617,0.0003145327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001530051,"about_ca_system_score_gemma":0.0002063414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003456851,"about_ca_topic_score_gemma":0.0005803624,"domain_scores_codex":[0.999729,0.00003765645,0.00002433269,0.00005169557,0.0001270012,0.00003025674],"domain_scores_gemma":[0.9998982,0.00002103622,0.00003153303,0.000007783156,0.00003065592,0.00001081095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005541562,0.00006513411,0.0001383902,0.0001667252,0.00001024869,0.0001070031,0.00002699766,0.0004826512,0.9886502,0.0001043581,0.00006849811,0.01012438],"study_design_scores_gemma":[0.00003937883,0.002063692,0.002557834,0.00001251264,0.00003932261,0.0004022122,0.00004384391,0.005865376,0.9840631,0.00006106347,0.004827041,0.00002453885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.876871,0.007912708,0.1087822,0.0004801228,0.00009459242,0.0006148837,0.0005378862,0.000370259,0.004336373],"genre_scores_gemma":[0.8829827,0.006038831,0.102434,0.0001832588,0.00003455917,0.0005057597,0.000576923,0.0000703017,0.007173694],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.000857736,"threshold_uncertainty_score":0.002869427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117943248","doi":"10.4172/jbb.1000113","title":"Comparative Bioavailability: Two Pramipexole Formulations in Healthy Volunteers after a Single Dose Administration under Fasting Conditions","year":2012,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bioavailability; Pramipexole; Pharmacology; Medicine; Pharmacokinetics; Internal medicine; Parkinson's disease; Disease","authors":[{"name":"Eduardo Abib","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1465024108902202,"gpt":0.4379382427566109,"spread":0.2914358318663907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001201877,0.0007275212,0.001618968,0.0003375822,0.0005240696,0.0004626133,0.0002735831,0.001124452,0.003016716],"category_scores_gemma":[0.00122226,0.0004866036,0.0005191269,0.0002788334,0.0006390995,0.0005479935,0.0002707152,0.0009472675,0.0007800392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002350408,"about_ca_system_score_gemma":0.0004171024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006160464,"about_ca_topic_score_gemma":0.0006663812,"domain_scores_codex":[0.9994805,0.0001545655,0.00003732905,0.0001705508,0.0001047412,0.00005237539],"domain_scores_gemma":[0.9994782,0.0001272496,0.00009690848,0.00008059158,0.0001108037,0.0001063859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4070294,0.03001565,0.006847705,0.0009209468,0.000450096,0.0007894061,0.001022525,0.0004505029,0.5011055,0.0002617452,0.001231349,0.04987514],"study_design_scores_gemma":[0.019278,0.8038963,0.08299247,0.00003738821,0.0009068378,0.001468099,0.0004289689,0.001670086,0.08477665,0.0002664616,0.004182518,0.00009611619],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961333,0.001178712,0.0008421073,0.00005570551,0.00009987166,0.0005958893,0.0003478914,0.00005020699,0.0006963657],"genre_scores_gemma":[0.9902344,0.001401317,0.002716885,0.0002093774,0.000211831,0.001358336,0.0007376601,0.00002439044,0.003105907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003016716,"threshold_uncertainty_score":0.0100919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2519942097","doi":"","title":"Targeting cancer stem cells: Challenges and opportunities","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Dasatinib; Imatinib; Stem cell; Progenitor cell; Cancer research; Cancer stem cell; Medicine; Tyrosine kinase; Myeloid leukemia; CD34; Haematopoiesis; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Population; Immunology; Cancer; Leukemia; Biology; Internal medicine; Cell biology; Receptor","authors":[{"name":"Xiaoyan Jiang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08584506014930933,"gpt":0.295643831768893,"spread":0.2097987716195837,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001878779,0.0006154651,0.0007733362,0.001032044,0.001791064,0.003553497,0.001195158,0.002572604,0.0300759],"category_scores_gemma":[0.001719281,0.0002969746,0.000246856,0.001092191,0.002571841,0.001462523,0.00183361,0.003506578,0.00651665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01101267,"about_ca_system_score_gemma":0.0219853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1800522,"about_ca_topic_score_gemma":0.344897,"domain_scores_codex":[0.9991365,0.00006518701,0.00002485892,0.0001008925,0.0004510886,0.0002214739],"domain_scores_gemma":[0.9966739,0.0002804442,0.00007337666,0.00009246321,0.001681468,0.001198322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002041602,0.00009643884,0.001109208,0.00127757,0.00001880962,0.0004929808,0.0003628723,0.0004955356,0.01100003,0.03764976,0.4703867,0.476906],"study_design_scores_gemma":[0.00001937881,0.00005469124,0.0008416629,0.0004832169,0.00001002954,0.0002544069,0.0003011963,0.0002509213,0.001828703,0.005565764,0.9903685,0.00002160191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009456518,0.5781622,0.00636652,0.2448661,0.009950695,0.0001564658,0.0009642957,0.0004843058,0.149593],"genre_scores_gemma":[0.05995359,0.6914658,0.008046137,0.03570081,0.003912029,0.0001886045,0.000999609,0.00018485,0.1995485],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1800522,"threshold_uncertainty_score":0.3580083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2525897054","doi":"","title":"Some statistical issues on the evaluation of the similarity and interchangeability of biologics","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Interchangeability; Biosimilar; Bioequivalence; Risk analysis (engineering); Biochemical engineering; Computer science; Pharmacology; Biotechnology; Computational biology; Business; Medicine; Engineering; Pharmacokinetics; Biology","authors":[{"name":"László Endrényi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1081024618092854,"gpt":0.357205385288697,"spread":0.2491029234794116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4677377,0.001852445,0.003504865,0.005968791,0.002404626,0.005684209,0.005552441,0.005447644,0.003329313],"category_scores_gemma":[0.7197635,0.001123687,0.007183888,0.008175802,0.02066034,0.0055086,0.004530259,0.009226489,0.0005371847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004126562,"about_ca_system_score_gemma":0.003320021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001832503,"about_ca_topic_score_gemma":0.001199454,"domain_scores_codex":[0.3108844,0.5986769,0.02558085,0.01090847,0.05254332,0.001406027],"domain_scores_gemma":[0.06127748,0.8891921,0.01327857,0.02419152,0.01148799,0.0005722598],"domain_codex":"methods","domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.004438891,0.0007345648,0.03984874,0.005837236,0.005274418,0.002463594,0.003881489,0.02813825,0.005822957,0.452912,0.01887077,0.4317771],"study_design_scores_gemma":[0.0009092244,0.01003026,0.0430448,0.003527457,0.002832073,0.004147843,0.002144088,0.1173512,0.01861184,0.7223895,0.074256,0.0007558311],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.02478355,0.01427174,0.9299265,0.01595378,0.002312955,0.002111712,0.0005127165,0.0004872154,0.009639922],"genre_scores_gemma":[0.3389677,0.004332758,0.6283835,0.01280259,0.005693427,0.006205812,0.0006660547,0.0005528959,0.002395222],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.4677377,"threshold_uncertainty_score":0.6563742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2519144724","doi":"","title":"Biosimilars? pricing policies in Canada: A new challenge to provincial governments","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","authors":[{"name":"Mlanie Bourassa Forcier","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0248928237703576,"gpt":0.2675882434322147,"spread":0.2426954196618571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01025031,0.0004105651,0.001151981,0.002560576,0.01221344,0.01486718,0.004639434,0.01099665,0.01381312],"category_scores_gemma":[0.03085556,0.0009212826,0.001316881,0.005600952,0.004930706,0.004448156,0.002763887,0.01075334,0.0008422863],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2075894,"about_ca_system_score_gemma":0.5606069,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.992661,"about_ca_topic_score_gemma":0.9957374,"domain_scores_codex":[0.9823518,0.001536293,0.0005970342,0.0009569234,0.008478167,0.006079705],"domain_scores_gemma":[0.9407848,0.007389756,0.002443136,0.0008549199,0.02716904,0.02135839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003184246,0.0003336537,0.02982302,0.0005107251,0.0001773111,0.0006798076,0.003245458,0.003239255,0.00170239,0.1839759,0.6695039,0.1064902],"study_design_scores_gemma":[0.0003657988,0.0001297487,0.0877942,0.0014005,0.0001952381,0.0002772589,0.008750085,0.007169583,0.0009511465,0.03967187,0.8528411,0.0004535838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.03372904,0.005762863,0.0009208207,0.923797,0.001101315,0.00009624233,0.001354843,0.0001403055,0.03309756],"genre_scores_gemma":[0.6102409,0.01267082,0.008569903,0.30067,0.001426869,0.0001126212,0.001189239,0.0003019425,0.0648177],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7924106,"threshold_uncertainty_score":0.919084,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531190671","doi":"","title":"Free radical scavenging activity of the Malaysian Leech Saliva extract, Hirudinaria manillensis","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Leech Biology and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Leech; Pharmacy; Traditional medicine; Lozenge; Medicine; Chemistry; Family medicine; Geography; Archaeology; World Wide Web","authors":[{"name":"Abbas Mohammad Ghawi Abdualrahman MAbdualkader Ahmed Merzouk","is_ca":false},{"name":"Mohamed Alaama","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01980302655715786,"gpt":0.2683141007804675,"spread":0.2485110742233096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002219765,0.0003605074,0.0003358017,0.0003843828,0.0002115152,0.0002273763,0.0001390456,0.0002769212,0.001494854],"category_scores_gemma":[0.0001956025,0.0001173883,0.0003074428,0.0002106531,0.0001344353,0.000219317,0.0002302276,0.0003634481,0.0001747752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009464574,"about_ca_system_score_gemma":0.0002227328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007920287,"about_ca_topic_score_gemma":0.001287047,"domain_scores_codex":[0.9999148,0.00002165786,0.000008885264,0.0000103363,0.0000327188,0.0000116707],"domain_scores_gemma":[0.9999149,0.00001936402,0.00001906641,0.00000535338,0.00002516576,0.00001622552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002804254,0.000167861,0.0005391242,0.0002764224,0.00002321975,0.0001071043,0.00004934051,0.00005423591,0.9867714,0.00005746352,0.0001168117,0.01155654],"study_design_scores_gemma":[0.0001752125,0.01051227,0.03951388,0.00008854965,0.0003648758,0.001180641,0.0002910195,0.0006275575,0.9393972,0.0001388904,0.007666221,0.00004366269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840402,0.01317851,0.0006722988,0.0002636121,0.0000816933,0.00006675979,0.0002007851,0.00003059385,0.001465613],"genre_scores_gemma":[0.9920877,0.003843078,0.001263535,0.0001787957,0.00006205922,0.00002465186,0.0002727641,0.0000041495,0.002263315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001494854,"threshold_uncertainty_score":0.00500077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2522289024","doi":"","title":"Regulatory consideration of the assessment of biosimilar products","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Harmonization; Scope (computer science); Interchangeability; Risk analysis (engineering); Business; Product (mathematics); Order (exchange); Bioequivalence; Medicine; Biotechnology; Pharmacology; Computer science; Finance; Pharmacokinetics","authors":[{"name":"Jun Wang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0237267121275939,"gpt":0.2906560368767194,"spread":0.2669293247491255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1133766,0.00134259,0.001839237,0.004764536,0.002417055,0.009836876,0.005188024,0.0221872,0.003395591],"category_scores_gemma":[0.1391113,0.0008146903,0.003320185,0.002536074,0.00693711,0.004803856,0.002877118,0.00841897,0.002126062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004171154,"about_ca_system_score_gemma":0.01849566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003384735,"about_ca_topic_score_gemma":0.002557809,"domain_scores_codex":[0.8138182,0.08749231,0.01415302,0.00510043,0.07639045,0.003045561],"domain_scores_gemma":[0.8548957,0.05606262,0.01484545,0.009207921,0.06197143,0.003016748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000913584,0.0006398964,0.005088442,0.005939271,0.0003923908,0.001864678,0.001874209,0.004260248,0.03518632,0.3346041,0.1713731,0.4378637],"study_design_scores_gemma":[0.0002575972,0.001679577,0.007955804,0.007094353,0.0003537483,0.001871617,0.0008651254,0.003692233,0.01609416,0.05719886,0.9027463,0.0001906188],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.04987418,0.147407,0.1157354,0.1878648,0.02224637,0.004700141,0.00235439,0.00154721,0.4682705],"genre_scores_gemma":[0.5835955,0.06831435,0.1425575,0.1275357,0.01433024,0.004530062,0.002635496,0.0006217986,0.05587925],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1133766,"threshold_uncertainty_score":0.5995997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}